Ray-David, H <br/><br/>
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.  [electronic resource] 

 -  Oncogene  Sep 2013 
 - 4480-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2012.472  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line<br/>Checkpoint Kinase 1<br/>DNA Damage<br/>Drug Resistance, Neoplasm--genetics<br/>G2 Phase Cell Cycle Checkpoints<br/>Gene Silencing<br/>Humans<br/>Melanoma--genetics<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Kinases--metabolism<br/>Proto-Oncogene Proteins p21(ras)--metabolism<br/>Ribosomal Protein S6 Kinases, 90-kDa--antagonists & inhibitors<br/>Signal Transduction